Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
暂无分享,去创建一个
M. Farrer | K. Alberti | P. Winocour | F. Game | H. Neil | M. Laker | C. Albers | P. Adams | F. Game | H. Neil
[1] V. Armstrong,et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.
[2] N. Morton,et al. Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.
[3] R. Ferrell,et al. Expressed hypervariable polymorphism of apolipoprotein (a). , 1991, American journal of human genetics.
[4] R. Krauss,et al. Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. , 1992, American Journal of Human Genetics.
[5] S. Marcovina,et al. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. , 1993, Biochemical and biophysical research communications.
[6] J. Fruchart,et al. Black-white differences in serum Lp(a) lipoprotein levels. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[7] J. Guyton,et al. Isolation and characterization of the two major apoproteins in human lipoprotein [a]. , 1987, Journal of lipid research.
[8] G. Fless. Chapter 3 – Heterogeneity of Particles Containing the Apo B-Apo(a) Complex , 1990 .
[9] L. Wilhelmsen,et al. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.
[10] K. Alberti,et al. Microalbuminuria and associated cardiovascular risk factors in the community. , 1992, Atherosclerosis.
[11] M. Debakey,et al. Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. , 1989, Arteriosclerosis.
[12] J. Morrisett,et al. Chapter 4 – Structural Properties of Apo(a): A Major Apoprotein of Human Lipoprotein(a) , 1990 .
[13] D. Slone,et al. Critical Variables in the Radioimmunoassay of Serum Insulin Using the Double Antibody Technic , 1965, Diabetes.
[14] V. Armstrong,et al. Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). , 1985, Journal of lipid research.
[15] A. Scanu,et al. A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.
[16] M. Dietel,et al. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.
[17] K. Sperling,et al. Large human Y chromosome with two fluorescent bands , 1971, Clinical genetics.
[18] D. Rouy,et al. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[19] V. Armstrong,et al. Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation. , 1991, Journal of lipid research.
[20] A. Scanu,et al. Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). , 1986, The Journal of biological chemistry.
[21] E. Boerwinkle,et al. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[22] M. Leon,et al. Emergent Use of Balloon‐Expandable Coronary Artery Stenting for Failed Percutaneous Transluminal Coronary Angioplasty , 1992, Circulation.
[23] G. Utermann,et al. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.
[24] A. Sharrett,et al. Lipoprotein[a] as a risk factor for preclinical atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[25] S. Srinivasan,et al. Racial (Black‐White) Differences in Serum Lipoprotein (a) Distribution and Its Relation to Parental Myocardial Infarction in Children: Bogalusa Heart Study , 1991, Circulation.
[26] K. Berg. A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.
[27] S J Pocock,et al. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. , 1981, British medical journal.
[28] G. De Backer,et al. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. , 1992, Clinical chemistry.
[29] K. Berg,et al. Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor , 1981, Clinical genetics.
[30] D. Rader,et al. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. , 1993, The Journal of clinical investigation.
[31] G. Dahlén. Chapter 11 – Incidence of Lp(a) Lipoprotein among Populations , 1990 .
[32] P. Savage,et al. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[33] E. Boerwinkle,et al. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. , 1991, The Journal of clinical investigation.
[34] W. Kohr,et al. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Boerwinkle,et al. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Farrer,et al. A simple, sensitive technique for classification of apolipoprotein(a) isoforms by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[37] G. Kostner,et al. Interaction of lipoprotein Lp[a] with the B/E-receptor: a study using isolated bovine adrenal cortex and human fibroblast receptors. , 1990, Journal of lipid research.
[38] E Marth,et al. Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.
[39] G. Assmann,et al. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. , 1990, Clinical chemistry.
[40] H. Keen. Diabetes Survey in Bedford 1962 , 1964, Proceedings of the Royal Society of Medicine.
[41] A. Gotto,et al. CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .
[42] A. Scanu,et al. Isolation of apolipoprotein(a) from lipoprotein(a). , 1985, Journal of lipid research.
[43] J. Breslow,et al. Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. , 1989, The Journal of clinical investigation.
[44] R. Lawn,et al. 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[46] C. Ehnholm,et al. Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. , 1971, Biochimica et biophysica acta.
[47] J. Beranek. Are restenosis cells containing nonmuscle myosin really vascular smooth muscle cells? , 1992, Circulation.
[48] A. Soutar,et al. Detection and quantitation of apolipoprotein(a) mRNA in human liver and its relationship with plasma lipoprotein(a) concentration. , 1991, Atherosclerosis.
[49] S. Marcovina,et al. The unique lipoprotein(a): properties and immunochemical measurement. , 1990, Clinical chemistry.
[50] E. Plow,et al. Chapter 8 – Relationship between Plasminogen Receptors and Lp(a) , 1990 .
[51] E. Boerwinkle,et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.
[52] H. Yamaguchi,et al. Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases. , 1992, Atherosclerosis.
[53] L. Hunt,et al. APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE , 1988, The Lancet.
[54] M. Frick,et al. Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease , 1974, Clinical genetics.
[55] E. Boerwinkle,et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.
[56] B. Lewis,et al. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain , 1988, British medical journal.
[57] W. Patsch,et al. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. , 1990, Journal of lipid research.
[58] M. Kameyama,et al. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. , 1986, Atherosclerosis.